Collegium Pharmaceutical, Inc. COLL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $74.95M+19.2% | $62.87M+7.6% | $58.44M+61.1% | $36.27M-17.4% | $43.89M-36.6% | ||
| $3.55M-15.0% | $4.18M-2.7% | $4.3M+2.1% | $4.21M+4.5% | $4.03M+4.5% | ||
| $41.26M-1.5% | $41.91M+5.4% | $39.75M+6.7% | $37.26M+2.2% | $36.45M+12.5% | ||
| -$26.09M-1.7% | -$25.66M+0.3% | -$25.74M-15.2% | -$22.34M+2.6% | -$22.94M+14.4% | ||
| $4.79M-10.3% | $5.34M-2.7% | $5.49M+2.5% | $5.35M-4.4% | $5.6M-6.9% | ||
| $60K+100% | -$17.2M-418% | $5.42M+135% | -$15.32M-261% | $9.52M+111% | ||
| $5.62M+3.1% | $5.45M+4,597% | $116K+102% | -$6.87M+38.7% | -$11.21M+19.5% | ||
| —— | —— | —— | —— | $4.37M+136% | ||
| —— | —— | —— | —— | —— | ||
| -$6.44M-181% | $7.97M+360% | $1.73M-92.6% | $23.5M-2.7% | $24.17M+71.7% | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | —— | $186.26M+12.7% | ||
| -$396K+66.5% | -$1.18M+71.0% | -$4.08M-0.5% | -$4.06M-9.7% | -$3.7M-27.0% | ||
| $331.04M+0.5% | $329.32M+13.2% | $290.92M+36.9% | $212.48M+2.4% | $207.44M-3.1% | ||
| $1.21M-30.3% | $1.74M+7.3% | $1.62M-3.3% | $1.68M-10.9% | $1.88M+13.9% | ||
| -$52.23M+17.8% | -$63.53M-15.0% | -$55.23M+79.8% | -$273.32M+2.1% | -$279.31M+2.9% | ||
| $626.66M-1.4% | $635.56M+884% | $64.58M+33.3% | $48.44M-38.0% | $78.13M-27.5% | ||
| $3.12M-27.1% | $4.28M+23.4% | $3.47M+58.9% | $2.18M-71.3% | $7.59M-25.9% | ||
| $17.69M+37.7% | $12.85M+4.7% | $12.26M+7.2% | $11.44M-32.3% | $16.89M-11.9% | ||
| —— | —— | —— | $7.56M+1,261% | $555K— | ||
| -$106.35M+3.5% | -$110.25M+15.0% | -$129.7M— | —— | —— | ||
| $172.46M+10.9% | $155.55M— | —— | —— | —— | ||
| $69.18M+0.6% | $68.76M-4.9% | $72.29M+5.6% | $68.43M+2.7% | $66.66M+6.8% | ||
| $57.63M-4.0% | $60.04M+24.1% | $48.38M-0.2% | $48.48M-10.8% | $54.37M+4.4% | ||
| $926K-13.6% | $1.07M-10.2% | $1.19M-19.2% | $1.48M-23.7% | $1.94M-4.5% | ||
| $4.79M-10.3% | $5.34M-2.7% | $5.49M+2.5% | $5.35M-4.4% | $5.6M-6.9% | ||
| —— | —— | —— | —— | $186.26M+12.7% | ||
| -$396K+66.5% | -$1.18M+71.0% | -$4.08M-0.5% | -$4.06M-9.7% | -$3.7M-27.0% | ||
| $3.55M-15.0% | $4.18M-2.7% | $4.3M+2.1% | $4.21M+4.5% | $4.03M+4.5% | ||
| $2.13M-25.4% | $2.85M— | —— | —— | —— | ||
| -$6.44M-181% | $7.97M+360% | $1.73M-92.6% | $23.5M-2.7% | $24.17M+71.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $416K+478% | -$110K-7.8% | -$102K-8.5% | ||
| —— | —— | —— | —— | —— | ||
| $626.66M-1.4% | $635.56M+884% | $64.58M+33.3% | $48.44M-38.0% | $78.13M-27.5% | ||
| $526K+64.9% | $319K-11.5% | $360.25K+66.4% | $216.5K+56.0% | $138.75K-25.0% | ||
| —— | $0-100% | $1.02M-50.0% | $2.05M-33.3% | $3.07M-25.0% | ||
| —— | —— | —— | —— | $0— | ||
| —— | —— | —— | $7.56M+1,261% | $555K— | ||
| —— | $0-100% | $24.75K-50.0% | $49.5K-33.3% | $74.25K-25.0% | ||
| $57.63M-4.0% | $60.04M+24.1% | $48.38M-0.2% | $48.48M-10.8% | $54.37M+4.4% | ||
| $329.83M+0.7% | $327.58M+13.2% | $289.3M+37.1% | $211.05M+2.5% | $205.8M-3.2% | ||
| $329.83M+0.7% | $327.58M+13.2% | $289.3M+37.1% | $211.05M+2.5% | $205.8M-3.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Collegium Pharmaceutical, Inc. generate?
- Collegium Pharmaceutical, Inc. (COLL) generated $331.0M in operating cash flow over the trailing twelve months.
- What is Collegium Pharmaceutical, Inc.'s free cash flow?
- After $1.2M of capital expenditures, Collegium Pharmaceutical, Inc.'s free cash flow was $329.8M over the trailing twelve months, up 60.3% year over year.
- Where does Collegium Pharmaceutical, Inc.'s cash flow data come from?
- Every line is extracted from Collegium Pharmaceutical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
